Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg

NCT02485028 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction Potentiation

Interventions

DRUG: Dapoxetine 30mg tablet
DRUG: Mirodenafil 50mg tablet

Sponsor

SK Chemicals Co., Ltd.